Literature DB >> 10790133

Evaluation of quantitative PCR and branched-chain DNA assay for detection of hepatitis B virus DNA in sera from hepatocellular carcinoma and liver transplant patients.

T Chen1, J M Luk, S T Cheung, W C Yu, S T Fan.   

Abstract

This study evaluated the applicability of quantitative PCR (Q-PCR) and branched-chain DNA assays for detection of hepatitis B virus (HBV) DNA in sera. For 42 samples, the detection rates were 81 and 41%, respectively, with a correlation coefficient of 0.633. The Q-PCR is useful for early monitoring of HBV load in high-risk patients.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10790133      PMCID： PMC86641     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  22 in total

1.  The estimation of distances between specific backbone-labeled sites in DNA using fluorescence resonance energy transfer.

Authors:  H Ozaki; L W McLaughlin
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

2.  A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.

Authors:  R P Perrillo; E R Schiff; G L Davis; H C Bodenheimer; K Lindsay; J Payne; J L Dienstag; C O'Brien; C Tamburro; I M Jacobson; R Sampliner; D Feit; J Lefkowitch; M Kuhns; C Meschievitz; B Sanghvi; J Albrecht; A Gibas
Journal:  N Engl J Med       Date:  1990-08-02       Impact factor: 91.245

3.  Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses.

Authors:  M S Urdea; T Horn; T J Fultz; M Anderson; J A Running; S Hamren; D Ahle; C A Chang
Journal:  Nucleic Acids Symp Ser       Date:  1991

4.  [Hepatitis B virus replication status and its response to surgery for tumor in hepatocellular carcinoma patients with positive markers of HBV].

Authors:  T Chen; Q Ou; J Chen; Q Deng; F Zhang
Journal:  Zhonghua Wai Ke Za Zhi       Date:  1998-11

Review 5.  Hepatitis B virus. The major etiology of hepatocellular carcinoma.

Authors:  R P Beasley
Journal:  Cancer       Date:  1988-05-15       Impact factor: 6.860

6.  Hepatitis B virus replication in Chinese patients with hepatocellular carcinoma.

Authors:  A S Lok; O C Ma
Journal:  Hepatology       Date:  1990-09       Impact factor: 17.425

7.  Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon.

Authors:  G Pastore; T Santantonio; M Milella; L Monno; N Mariano; R Moschetta; L Pollice
Journal:  J Hepatol       Date:  1992-03       Impact factor: 25.083

8.  Interferon alfa therapy in patients with chronic hepatitis B virus infection. Effects on hepatitis B virus DNA in the liver.

Authors:  A S Lok; O C Ma; J Y Lau
Journal:  Gastroenterology       Date:  1991-03       Impact factor: 22.682

9.  A comparison of non-radioisotopic hybridization assay methods using fluorescent, chemiluminescent and enzyme labeled synthetic oligodeoxyribonucleotide probes.

Authors:  M S Urdea; B D Warner; J A Running; M Stempien; J Clyne; T Horn
Journal:  Nucleic Acids Res       Date:  1988-06-10       Impact factor: 16.971

10.  Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays.

Authors:  F Lunel; P Cresta; D Vitour; C Payan; B Dumont; L Frangeul; D Reboul; C Brault; J C Piette; J M Huraux
Journal:  Hepatology       Date:  1999-02       Impact factor: 17.425
View more
  6 in total

1.  Evaluation of the COBAS TaqMan 48 real-time PCR system for quantitation of hepatitis B virus DNA.

Authors:  Rafael M Gordillo; Juan Gutiérrez; Manuel Casal
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

2.  Comparative evaluation of semiautomated COBAS AMPLICOR hepatitis B virus (HBV) monitor test and manual microwell plate-based AMPLICOR HBV MONITOR test.

Authors:  I J Marin; M Poljak; K Seme; J Meglic-Volkar; M Maticic; G Lesnicar; V Brinovec
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

3.  Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter study.

Authors:  Syria Laperche; Vincent Thibault; Françoise Bouchardeau; Sophie Alain; Sandrine Castelain; Michelle Gassin; Marie Gueudin; Philippe Halfon; Sylvie Larrat; Françoise Lunel; Michèle Martinot-Peignoux; Bernard Mercier; Jean-Michel Pawlotsky; Bruno Pozzetto; Anne-Marie Roque-Afonso; Françoise Roudot-Thoraval; Karine Sauné; Jean-Jacques Lefrère
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

4.  A review of the one-year incidence of resistance to lamivudine in the treatment of chronic hepatitis B : Lamivudine resistance.

Authors:  Hie-Won Hann; Vicki L Gregory; Jonathan S Dixon; Keith F Barker
Journal:  Hepatol Int       Date:  2008-10-21       Impact factor: 6.047

5.  Establishment and assessment of two methods for quantitative detection of serum duck hepatitis B virus DNA.

Authors:  Ya-Xi Chen; Ai-Long Huang; Zhen-Yuan Qi; Shu-Hua Guo
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

6.  Anti-hepatitis B virus X protein in sera is one of the markers of development of liver cirrhosis and liver cancer mediated by HBV.

Authors:  Hang Zhang; Lian-Ying Wu; Shuai Zhang; Li-Yan Qiu; Nan Li; Xuan Zhang; Xue-Zhi Zhang; Chang-Liang Shan; Li-Hong Ye; Xiao-Dong Zhang
Journal:  J Biomed Biotechnol       Date:  2009-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.